ESTRF yields 20000000.00% · PFE yields 6.13%● Live data
📍 ESTRF pulled ahead of the other in Year 1
Combined, ESTRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESTRF + PFE for your $10,000?
Estre Ambiental, Inc., a waste management company, provides a range of waste-related and environmental services for municipal, commercial, and industrial customers in Brazil and Latin America. The company operates through four segments: Collection & Cleaning Services, O&G, Landfill, and Value Recovery. The Collection & Cleaning Services segment is involved in the industrial collection from large businesses, as well as local household collection, transportation, and temporary storage for environmental liability emergencies and industrial accidents, as well as in the preparation of waste for final disposal. The O&G segment engages in the provision of soil treatment and restoration services; and cleaning of storage tanks for the oil and gas industry. The Landfill segment provides treatment and waste disposal services, such as ground sealing, drainage and treatment of percolated liquid, rainwater catchment, and soil treatment with hydrocarbons. The Value Recovery segment is involved in the provision of energy recycling services; and dismantlement of electrical-electronic products. The company also engages in the collection and burning of landfill biogas, and electricity generation businesses. In addition, it offers environmental consulting, laboratory analysis, environmental consulting, recycling, and energy use services. Estre Ambiental, Inc. was founded in 1999 and is headquartered in São Paulo, Brazil.
Full ESTRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.